Allergan Plc: Continue to Strengthen Its Presence and Innovation in GI market

Reportedly, on Oct 3, 2016, Allegran Plc; headquartered in New Jersey (US) announced that it has entered into an exclusive worldwide licensing agreement with MedImmune (AstraZeneca’s R&D arm) to develop and commercialize MEDI2070 which finally get completed on Nov 17, 2016. As per the terms of the agreement, Allergan will pay an upfront payment to […]

Allergan Plc: Continue to Strengthen Its Presence and Innovation in GI market

Reportedly, on Oct 3, 2016, Allegran Plc; headquartered in New Jersey (US) announced that it has entered into an exclusive worldwide licensing agreement with MedImmune (AstraZeneca’s R&D arm) to develop and commercialize MEDI2070 which finally get completed on Nov 17, 2016. As per the terms of the agreement, Allergan will pay an upfront payment to […]